LYSODREN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Mitotane.
| Product ID | 0015-3080_bacf9c5c-6119-4219-8d8d-f3c2db33e18e | 
| NDC | 0015-3080 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | LYSODREN | 
| Generic Name | Mitotane | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2009-06-01 | 
| Marketing End Date | 2021-03-31 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA016885 | 
| Labeler Name | E.R. Squibb & Sons, L.L.C. | 
| Substance Name | MITOTANE | 
| Active Ingredient Strength | 500 mg/1 | 
| Pharm Classes | Cytochrome P450 3A4 Inducers [MoA] | 
| NDC Exclude Flag | N | 
| Marketing Start Date | 2009-06-01 | 
| Marketing End Date | 2021-03-31 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA016885 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2009-06-01 | 
| Marketing End Date | 2021-03-31 | 
| Ingredient | Strength | 
|---|---|
| MITOTANE | 500 mg/1 | 
| SPL SET ID: | e9fba7d4-a0ec-4bfa-9b5b-ec97a9710fd3 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0015-3080 | LYSODREN | MITOTANE | 
| 76336-080 | Lysodren | mitotane | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() LYSODREN  73358100  1243390 Live/Registered  | 
        Bristol-Myers Company  1982-04-05  | 
![]() LYSODREN  73156066  1099245 Live/Registered  | 
        CALBIOCHEM-BEHRING CORP.  1978-01-23  |